Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway
NCT ID: NCT04209491
Last Updated: 2020-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2019-09-09
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Hypothesis is that co-follow-up by a doctor and a nurse coordinator reduces time between referral to treatment, average lengths of stay, unscheduled readmissions or early emergency visits, compared to follow-up that does not involve a nurse coordinator.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
NCT04340986
Outpatient Care Pathway for Patients Treated Intra-arterially for Primary Liver Cancer
NCT06990659
Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas
NCT04172194
Effects of Antiviral Therapy on Patients With HBV-related HCC
NCT05406089
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
NCT06086002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Describe the roles and missions of professionals dedicated to the coordination of care pathways for patients with HCC
Secondary objectives:
Compare the indicators of quality of care in HCC centres with a nurse coordinator:
1. Timeframe in treatment:
* timeframe between the first contact with the HCC centre and the first interventional radiology treatment.
* timeframe between the first contact with the centre and the first presentation at a multidisciplinary team meeting (MDT)
* time between the first contact with the centre and the diagnostic consultation
* timeframe between the first contact with the centre and discharge from the hospital
* timeframe between the first interventional radiology procedure and the next for the subgroup of patients who have multiple procedures during the follow-up period
* timeframe between the first contact with the nurse coordinator of the centre and discharge from the hospital.
2. The average length of stay of hospitalization
3. The number of visits to the emergency unit during the first month following the radiology intervention
4. The number of unscheduled readmissions during the first month following the intervention.
Assess the feasibility of collecting the above-mentioned timeframe and variables and the patients and carers feedback on the coordination of the care pathway Describe the organization of care pathways for patients with HCC in centres with or without a nurse coordinator.
Research method: This is a retrospective descriptive pilot study. It aims to describe the organization of care.
Population: Patient with a diagnosis of localized hepatocellular carcinoma.
Data processing:
* Feasibility questionnaires will be sent by email.
* The interviews will be transcribed and coded with NVivo® software
* Patient data will be collected in the ecrf
* Data processing from anonymized files by the authors of the research only. All data will be centralized at Bichat Hospital (URC Paris Nord) for statistical analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active list of patients followed for a HCC of at least 70 / year
* Reply to the feasibility questionnaire within 60 days from receipt of the email
Exclusion Criteria
* Hospitalised for a first interventional radiology treatment (radioembolisation, transarterial chemoembolization or percutaneous ablation) in one of the centres included in the study between July 1, 2017 and December 31, 2017
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie DEVICTOR
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BEAUJON Hospital
Clichy-sous-Bois, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohamed BOUATTOUR, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP 180129
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.